Corramedical Inc.

Corramedical Inc. specializes in blood and tissue storage containers, with a focus on systems designed to capture and preserve biopsy samples. Their primary offering, the Crow’s Nest Biopsy Catchment System, is engineered to safely collect and contain tissue specimens during medical procedures for later analysis or processing.

Corramedical Inc. is headquartered in the United States. The company’s location is relevant for understanding its regulatory framework and operational reach, particularly in the US market.

Corramedical Inc.’s devices are classified under Class I in the US regulatory system. This classification applies to products posing the lowest risk, often involving minimal or non-invasive use, such as biopsy catchment systems. Class I devices typically undergo general controls rather than specific regulatory scrutiny.

Yes, Corramedical Inc.’s devices are included in the FDA’s Unique Device Identifier (UDI) database. Listing in the UDI system ensures traceability and transparency in the supply chain, allowing healthcare providers and regulators to identify and track specific devices like the Crow’s Nest Biopsy Catchment System.